Spectral Diagnostics (EDTXF) Projected to Post Earnings on Friday

Spectral Diagnostics (OTCMKTS:EDTXF) will likely be posting its results before the market opens on Friday, August 7th. Analysts expect Spectral Diagnostics to announce earnings of ($0.0068) per share and revenue of $0.4250 million for the quarter.

Spectral Diagnostics (OTCMKTS:EDTXF) last released its earnings results on Friday, May 8th. The company reported ($0.01) EPS for the quarter, meeting analysts’ consensus estimates of ($0.01). The business had revenue of $0.64 million during the quarter, compared to analyst estimates of $0.54 million.

Spectral Diagnostics Stock Up 6.1%

OTCMKTS:EDTXF opened at $1.00 on Wednesday. Spectral Diagnostics has a fifty-two week low of $0.59 and a fifty-two week high of $1.31. The stock has a market cap of $292.55 million, a PE ratio of -9.97 and a beta of 0.13. The firm’s fifty day simple moving average is $0.98 and its 200-day simple moving average is $0.98.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.